The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study

[Display omitted] •Previous studies and meta-analysis have suggested the possible existence of sex-related differences in response to immunotherapy.•We conducted a meta-analysis aimed at systematically exploring the presence of sex-related differences in patients treated with ICI.•This study is the...

Full description

Saved in:

Bibliographic Details
Published in:	Critical reviews in oncology/hematology Vol. 170; p. 103596
Main Authors:	Santoni, Matteo, Rizzo, Alessandro, Mollica, Veronica, Matrana, Marc R., Rosellini, Matteo, Faloppi, Luca, Marchetti, Andrea, Battelli, Nicola, Massari, Francesco
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.02.2022
Subjects:	Atezolizumab Avelumab Durvalumab Female Gender Humans Immune Checkpoint Inhibitors Immunotherapy Lung Neoplasms - drug therapy Male Neoplasms - drug therapy Nivolumab Pembrolizumab Sex Pembrolizumab Durvalumab Nivolumab Immunotherapy Sex Avelumab Gender Atezolizumab
ISSN:	1040-8428, 1879-0461, 1879-0461
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!